(Q73459539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

G P Murphy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A A Elgamal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M J Troychak

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G M Kenny

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

315-317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

Two different lymph node metastatic patterns of a prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000301%2942%3A4%3C315%3A%3AAID-PROS9%3E3.0.CO%3B2-S

10.1002/(SICI)1097-0045(20000301)42:4<315::AID-PROS9>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10679761%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference